Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Recent business news covers mortgage implications after house destruction, wealth-building strategies, prescription drug price cuts, and the rise and fall of Forever 21. Read more...

Investors face a potentially volatile Friday with a key jobs report and Powell's speech looming. Concerns also rise as U.S. layoffs hit a post-pandemic high, while Hims & Hers stock suffers a sharp decline. Read more...